Pharmaceuticals

Europe Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

  • QYR908545
  • 129 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Viral Vectors and Plasmid DNA Manufacturing

Revenue, means the sales value of Viral Vectors and Plasmid DNA Manufacturing

This report studies sales (consumption) of Viral Vectors and Plasmid DNA Manufacturing in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Aldevron

Eurogentec

Richter-Helm

BioReliance (A Part of SAFC Commercial)

Biovian

Brammer Bio

Cell and Gene Therapy Catapult

Cobra Biologics

FinVector

FUJIFILM Diosynth Biotechnologies

Lonza

MassBiologics

MolMed

Oxford BioMedica

Sanofi (CEPiA, Sanofi Pasteur, Genzyme)

Spark Therapeutics

uniQure

ViGene Biosciences

Wuxi AppTec

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Plasmid DNA

Viral Vectors

Non-Viral Vectors

Split by application, this report focuses on sales, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in each application, can be divided into

Cancers

Inherited Disorders

Viral Infections

Others

Table of Contents

Europe Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

1 Viral Vectors and Plasmid DNA Manufacturing Overview

1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing

1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing

1.2.1 Plasmid DNA

1.2.2 Viral Vectors

1.2.3 Non-Viral Vectors

1.3 Application of Viral Vectors and Plasmid DNA Manufacturing

1.3.1 Cancers

1.3.2 Inherited Disorders

1.3.3 Viral Infections

1.3.4 Others

1.4 Viral Vectors and Plasmid DNA Manufacturing Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)

1.5.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)

1.5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

2 Europe Viral Vectors and Plasmid DNA Manufacturing by Manufacturers, Type and Application

2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers

2.1.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Type

2.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)

2.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)

2.3 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Countries

2.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Countries (2012-2017)

2.4 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume) by Application

3 Germany Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

3.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

3.1.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

3.1.2 Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

3.1.3 Germany Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

3.2 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

3.3 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

3.4 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

4 France Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

4.1 France Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

4.1.1 France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

4.1.2 France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

4.1.4 France Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

4.2 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

4.3 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

4.4 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

5 UK Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

5.1 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

5.1.1 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

5.1.2 UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

5.1.5 UK Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

5.2 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

5.3 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

5.4 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

6 Russia Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

6.1 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

6.1.1 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

6.1.2 Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

6.1.6 Russia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

6.2 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

6.3 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

6.4 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

7 Italy Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

7.1 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

7.1.1 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

7.1.2 Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

7.1.7 Italy Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

7.2 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

7.3 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

7.4 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

8 Spain Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

8.1 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

8.1.1 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

8.1.2 Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

8.1.8 Spain Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

8.2 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

8.3 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

8.4 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

9 Benelux Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)

9.1 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)

9.1.1 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

9.1.2 Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

9.2 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers

9.3 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type

9.4 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application

10 Europe Viral Vectors and Plasmid DNA Manufacturing Manufacturers Analysis

10.1 Aldevron

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.1.2.1 Plasmid DNA

10.1.2.2 Viral Vectors

10.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Eurogentec

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.2.2.1 Plasmid DNA

10.2.2.2 Viral Vectors

10.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Richter-Helm

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.3.2.1 Plasmid DNA

10.3.2.2 Viral Vectors

10.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 BioReliance (A Part of SAFC Commercial)

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.4.2.1 Plasmid DNA

10.4.2.2 Viral Vectors

10.4.3 BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Biovian

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.5.2.1 Plasmid DNA

10.5.2.2 Viral Vectors

10.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Brammer Bio

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.6.2.1 Plasmid DNA

10.6.2.2 Viral Vectors

10.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Cell and Gene Therapy Catapult

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.7.2.1 Plasmid DNA

10.7.2.2 Viral Vectors

10.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Cobra Biologics

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.8.2.1 Plasmid DNA

10.8.2.2 Viral Vectors

10.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 FinVector

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.9.2.1 Plasmid DNA

10.9.2.2 Viral Vectors

10.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 FUJIFILM Diosynth Biotechnologies

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification

10.10.2.1 Plasmid DNA

10.10.2.2 Viral Vectors

10.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 Lonza

10.12 MassBiologics

10.13 MolMed

10.14 Oxford BioMedica

10.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)

10.16 Spark Therapeutics

10.17 uniQure

10.18 ViGene Biosciences

10.19 Wuxi AppTec

11 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis

11.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)

14.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.2 France Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.3 UK Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.4 Russia Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.5 Italy Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.6 Spain Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.7 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)

14.8 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)

14.9 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Viral Vectors and Plasmid DNA Manufacturing

Table Classification of Viral Vectors and Plasmid DNA Manufacturing

Figure Europe Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type in 2015

Figure Plasmid DNA Picture

Figure Viral Vectors Picture

Figure Non-Viral Vectors Picture

Table Application of Viral Vectors and Plasmid DNA Manufacturing

Figure Europe Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application in 2015

Figure Cancers Examples

Figure Inherited Disorders Examples

Figure Viral Infections Examples

Figure Others Examples

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)

Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales of Key Manufacturers (2015 and 2016)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers

Figure 2016 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Manufacturers (2015 and 2016)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers

Table 2016 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)

Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)

Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)

Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Type (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Countries (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Countries (2012-2017)

Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Countries (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Countries (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Countries (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application (2012-2017)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Application (2012-2017)

Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application (2012-2017)

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure France Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)

Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)

Table Viral Vectors and Plasmid DNA Manufacturing Basic Information List

Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Eurogentec Basic Information List

Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Richter-Helm Basic Information List

Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table BioReliance (A Part of SAFC Commercial) Basic Information List

Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Biovian Basic Information List

Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Brammer Bio Basic Information List

Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Cell and Gene Therapy Catapult Basic Information List

Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Cobra Biologics Basic Information List

Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table FinVector Basic Information List

Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table FUJIFILM Diosynth Biotechnologies Basic Information List

Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)

Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)

Table Lonza Basic Information List

Table MassBiologics Basic Information List

Table MolMed Basic Information List

Table Oxford BioMedica Basic Information List

Table Sanofi (CEPiA, Sanofi Pasteur, Genzyme) Basic Information List

Table Spark Therapeutics Basic Information List

Table uniQure Basic Information List

Table ViGene Biosciences Basic Information List

Table Wuxi AppTec Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing

Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis

Table Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015

Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing

Table Distributors/Traders List

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)

Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370